Skip to main content
. 2021 Aug 19;16(8):e0256368. doi: 10.1371/journal.pone.0256368

Table 1. Comparison of baseline characteristics in the primary groups that received ≥30 mL/Kg fluid bolus.

Case (CHF), n = 123 Control (non-CHF), n = 236 P-value
Age (years), m (SD) 72.28 (12.04) 59.87 (15.68) <0.001
Female, n (%) 59 (47.97) 124 (52.54) 0.67
Ethnicity, n (%) 0.48
    White 73 (59.35) 125 (52.97)
    African American 38 (30.89) 87 (36.86)
    Others 12 (9.76) 24 (10.17)
CCI, m (SD) 6.8 (2.57) 4.3 (3.16) <0.001
ESRD on HD, n (%) 10 (8.20) 15 (6.36) 0.51
Lactic Acid, (mmol/L), m (SD) 3.97 (2.65) 4.36 (3.46) 0.27
SBP (mmHg), m (SD) 86.47 (19.02) 89.91 (17.19) 0.08
DBP (mmHg), m (SD) 52.30 (13.65) 53.49 (12.93) 0.42
MAP (mmHg), m (SD) 63.63 (14.54) 65.55 (13) 0.20
HR (per minute), m (SD) 112.17 (28.95) 115.11 (25.07) 0.31
Temperature (°C), m (SD) 37.12 (1.47) 37.53 (1.42) 0.01
RR (per minute), m (SD) 22.1 (7.70) 22.49 (7.58) 0.64
WBC (109/L), m (SD) 14.98 (9.74) 16.04 (11.02) 0.36

m = mean; n = number; SD = Standard Deviation; CCI = Charlson-Comorbidity Index; ESRD on HD = End-Stage Renal Disease on Hemodialysis; SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; MAP = Mean Arterial Pressure; HR = Heart Rate; RR = Respiratory Rate; WBC = White Blood Cell. Significant P-values are in bold.